Citigroup’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-15,754
| Closed | -$1.14M | – | 7902 |
|
|
2020
Q4 | $1.14M | Sell |
15,754
-15,822
| -50% | -$828K | ﹤0.01% | 3411 |
|
|
2020
Q3 | $1.44M | Sell |
31,576
-26,406
| -46% | -$1.1M | ﹤0.01% | 2951 |
|
|
2020
Q2 | $2.62M | Buy |
57,982
+27,031
| +87% | +$1.21M | ﹤0.01% | 2492 |
|
|
2020
Q1 | $1.19M | Sell |
30,951
-5,746
| -16% | -$265K | ﹤0.01% | 2983 |
|
|
2019
Q4 | $1.7M | Buy |
36,697
+354
| +1% | +$15.3K | ﹤0.01% | 3175 |
|
|
2019
Q3 | $1.48M | Buy |
36,343
+11,088
| +44% | +$479K | ﹤0.01% | 3193 |
|
|
2019
Q2 | $1.22M | Sell |
25,255
-73
| -0.3% | -$3.84K | ﹤0.01% | 3404 |
|
|
2019
Q1 | $1.58M | Sell |
25,328
-27,910
| -52% | -$1.92M | ﹤0.01% | 2914 |
|
|
2018
Q4 | $3.18M | Sell |
53,238
-13,034
| -20% | -$783K | ﹤0.01% | 2250 |
|
|
2018
Q3 | $4.27M | Buy |
66,272
+50,189
| +312% | +$2.8M | ﹤0.01% | 2007 |
|
|
2018
Q2 | $724K | Sell |
16,083
-181
| -1% | -$7.22K | ﹤0.01% | 3703 |
|
|
2018
Q1 | $505K | Sell |
16,264
-4,620
| -22% | -$152K | ﹤0.01% | 3989 |
|
|
2017
Q4 | $626K | Sell |
20,884
-613
| -3% | -$17.8K | ﹤0.01% | 3871 |
|
|
2017
Q3 | $709K | Sell |
21,497
-7,089
| -25% | -$246K | ﹤0.01% | 3733 |
|
|
2017
Q2 | $957K | Buy |
28,586
+2,954
| +12% | +$88.1K | ﹤0.01% | 3366 |
|
|
2017
Q1 | $742K | Sell |
25,632
-35,497
| -58% | -$879K | ﹤0.01% | 3523 |
|
|
2016
Q4 | $1.37M | Buy |
61,129
+35,943
| +143% | +$703K | ﹤0.01% | 3373 |
|
|
2016
Q3 | $468K | Buy |
25,186
+21,973
| +684% | +$414K | ﹤0.01% | 3951 |
|
|
2016
Q2 | $52K | Sell |
3,213
-19,940
| -86% | -$293K | ﹤0.01% | 5553 |
|
|
2016
Q1 | $270K | Buy |
23,153
+13,954
| +152% | +$156K | ﹤0.01% | 4803 |
|
|
2015
Q4 | $107K | Buy |
9,199
+8,406
| +1,060% | +$106K | ﹤0.01% | 5325 |
|
|
2015
Q3 | $10K | Sell |
793
-1,717
| -68% | -$21.9K | ﹤0.01% | 6469 |
|
|
2015
Q2 | $24K | Buy |
2,510
+1,080
| +76% | +$9.99K | ﹤0.01% | 6009 |
|
|
2015
Q1 | $12K | Sell |
1,430
-3,185
| -69% | -$32.2K | ﹤0.01% | 6405 |
|
|
2014
Q4 | $46K | Buy |
4,615
+3,698
| +403% | +$31.7K | ﹤0.01% | 5753 |
|
|
2014
Q3 | $6K | Buy |
917
+694
| +311% | +$4.87K | ﹤0.01% | 6535 |
|
|
2014
Q2 | $2K | Buy |
+223
| New | +$1.77K | ﹤0.01% | 6857 |
|
|
2013
Q3 | – | Sell |
-3,049
| Closed | -$18K | – | 7256 |
|
|
2013
Q2 | $18K | Buy |
+3,049
| New | +$10.3K | ﹤0.01% | 5886 |
|
Other funds holding BEAT
Citigroup's BEAT Position: Q1 2021 in Review
Citigroup sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 15,754 shares — an estimated $1.14M sold.
Citigroup first reported a position in BEAT in Q2 2013 and held it in 28 quarters. The position peaked at $4.27M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Citigroup reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Citigroup sold 15,754 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.14M.
- Citigroup first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 28 quarters.
- Citigroup's BioTelemetry, Inc. position peaked at $4.27M in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Citigroup's 13F filing for Q1 2021, filed 13 May 2021.